Sino-U.S. Tianjin Shike Pharmaceutical Co., Ltd. (hereinafter referred to as Sino-U.S. Shike), a Sino foreign joint venture, was established in 1987. It is a consumer health care products company jointly invested by GlaxoSmithKline (GSK), one of the largest pharmaceutical factories in the world, Tianjin Zhongxin Pharmaceutical Group Co., Ltd. and Tianjin Taiping (Group) Co., Ltd.
Sino-U.S. Shike has always adhered to the concept of great love, and returned to the society with high-quality products and love. In 2008, in addition to the four OTC brands that consumers are familiar with, New Contac, Fenbid, Baiduobang and Shike Changchongqing, the Sino American Shike family also successfully launched the anti tooth sensitive toothpaste Comfortable, which is the first choice recommended by dentists worldwide; New Kangtaike and Fenbid brand families have added new members. In 2008, the new Kangtaike red heavy sense clothing was successfully launched; In 2009, the new headache outfit of Fenbid Phenol Coffee Tablets was successfully launched, and Sino US SmithKline will take better care of people's healthy lives.